Genetic loci associated with circulating levels of very long-chain saturated fatty acids

Journal of Lipid Research

Volumn 56, Issue 1, 2015, Pages 176-184

  Lemaitre, Rozenn N ^a   King, Irena B ^c   Kabagambe, Edmond K ^d   Wu, Jason H Y ^e   McKnight, Barbara ^b   Manichaikul, Ani ^f,g   Guan, Weihua ^h   Sun, Qi ^j,k   Chasman, Daniel I ^j   Foy, Millennia ^l   Wang, Lu ^j   Zhu, Jingwen ⁿ   Siscovick, David S ^a,b   Tsai, Michael Y ⁱ   Arnett, Donna K ^o   Psaty, Bruce M ^a,b,p   Djousse, Luc ^j,q   Chen, Yii Der I ^r   Tang, Weihong ^h   Weng, Lu Chen ^h   Wu, Hongyu ^k   Jensen, Majken K ^k   Chu, Audrey Y ^j   Jacobs, David R ^h   Rich, Stephen S ^f   Mozaffarian, Dariush ^j,k,s   Steffen, Lyn ^h   Rimm, Eric B ^j,k   Hu, Frank B ^j,k   Ridker, Paul M ^j   Fornage, Myriam ^l,m   Friedlander, Yechiel ^t   more..

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF VIRGINIA   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF TEXAS   (United States)

ⁿ UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^o UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^p CENTER FOR HEALTH STUDIES   (United States)

^q Division of SCI Research   (United States)

^r CEDARS SINAI MEDICAL CENTER   (United States)

^s TUFTS UNIVERSITY   (United States)

^t HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDIC ACID; BEHENIC ACID; LIGNOCERIC ACID; PHOSPHOLIPID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID; VERY LONG CHAIN SATURATED FATTY ACID; FATTY ACID;

ARTICLE; CERAMIDE SYNTHASE 4 GENE; COHORT ANALYSIS; FATTY ACID ANALYSIS; GENE; GENE LOCUS; GENETIC VARIABILITY; HUMAN; PHOSPHOLIPID BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SPHINGOLIPID METABOLISM; SPTLC3 GENE; BLOOD; GENETIC ASSOCIATION; META ANALYSIS; PROCEDURES;

COHORT STUDIES; FATTY ACIDS; GENETIC LOCI; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84920668691     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M052456     Document Type: Article

References (39)

1. Moser, A. B., N. Kreiter, L. Bezman, S. Lu, G. V. Raymond, S. Naidu, and H. W. Moser. 1999. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45: 100-110.
2. Kihara, A. 2012. Very long-chain fatty acids: elongation, physiology and related disorders. J. Biochem. 152: 387-395.
3. Quehenberger, O., A. M. Armando, A. H. Brown, S. B. Milne, D. S. Myers, A. H. Merrill, S. Bandyopadhyay, K. N. Jones, S. Kelly, R. L. Shaner, et al. 2010. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51: 3299-3305.
4. Sassa, T., S. Suto, Y. Okayasu, and A. Kihara. 2012. A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells. Biochim. Biophys. Acta. 1821: 1031-1037.
5. Iwabuchi, K., H. Nakayama, C. Iwahara, and K. Takamori. 2010. Signifi cance of glycosphingolipid fatty acid chain length on membrane microdomain-mediated signal transduction. FEBS Lett. 584: 1642-1652.
6. Grösch, S., S. Schiffmann, and G. Geisslinger. 2012. Chain length-specific properties of ceramides. Prog. Lipid Res. 51: 50-62.
7. Fretts, A. M., D. Mozaffarian, D. S. Siscovick, L. Djousse, S. R. Heckbert, I. B. King, B. McKnight, C. Sitlani, F. M. Sacks, X. Song, et al. 2014. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study. J. Am. Heart Assoc. 3: e000889.
8. Lemaitre, R. N., I. B. King, K. Rice, B. McKnight, N. Sotoodehnia, T. D. Rea, C. O. Johnson, T. E. Raghunathan, L. A. Cobb, D. Mozaffarian, et al. 2014. Erythrocyte very long-chain saturated fatty acids associated with lower risk of incident sudden cardiac arrest. Prostaglandins Leukot. Essent. Fatty Acids. 91: 149-153.
9. Forouhi, N. G., A. Koulman, S. J. Sharp, F. Imamura, J. Kröger, M. B. Schulze, F. L. Crowe, J. M. Huerta, M. Guevara, J. W. J. Beulens, et al. 2014. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2: 810-818.
10. US Department of Agriculture Agricultural Research Service. 2014. USDA National Nutrient Database for Standard Reference, Release 27. Accessed 10/1/2014 at http://www.ars.usda.gov/ba/bhnrc/ndl.
11. Garg, M. L., R. J. Blake, and R. B. Wills. 2003. Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. J. Nutr. 133: 1060-1063.
12. Lam, C., D. Wong, S. Cederbaum, B. Lim, and Y. Qu. 2012. Peanut consumption increases levels of plasma very long chain fatty acids in humans. Mol. Genet. Metab. 107: 620-622.
13. Jakobsson, A., R. Westerberg, and A. Jacobsson. 2006. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog. Lipid Res. 45: 237-249.
14. Guillou, H., D. Zadravec, P. G. Martin, and A. Jacobsson. 2010. The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog. Lipid Res. 49: 186-199.
15. Knopp, R. H., B. Retzlaff, C. Walden, B. Fish, B. Buck, and B. McCann. 2000. One-year effects of increasingly fat-restricted, carbohydrate- enriched diets on lipoprotein levels in free-living subjects. Proc. Soc. Exp. Biol. Med. 225: 191-199.
16. Hudgins, L. C., M. Hellerstein, C. Seidman, R. Neese, J. Diakun, and J. Hirsch. 1996. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J. Clin. Invest. 97: 2081-2091.
17. King, I. B., R. N. Lemaitre, and M. Kestin. 2006. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am. J. Clin. Nutr. 83: 227-236.
18. Lemaitre, R. N., D. S. Siscovick, E. M. Berry, J. D. Kark, and Y. Friedlander. 2008. Familial aggregation of red blood cell membrane fatty acid composition: the Kibbutzim Family Study. Metabolism. 57: 662-668.
19. Li, Y., C. J. Willer, J. Ding, P. Scheet, and G. R. Abecasis. 2010. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34: 816-834.
20. Servin, B., and M. Stephens. 2007. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 3: e114.
21. Browning, B. L., and S. R. Browning. 2009. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet. 84: 210-223.
22. Marchini, J., B. Howie, S. Myers, G. McVean, and P. Donnelly. 2007. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39: 906-913.
23. Sitlani, C. M., and B. McKnight. 2011. Relative efficiency of trend tests with misspecified genetic models in stratified analyses of case-control or cohort data. Hum. Hered. 71: 246-255.
24. Skol, A. D., L. J. Scott, G. R. Abecasis, and M. Boehnke. 2006. Joint analysis is more efficient than replication-based analysis for twostage genome-wide association studies. Nat. Genet. 38: 209-213. 209-213.
25. Thompson, S. G., and S. J. Sharp. 1999. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat. Med. 18: 2693-2708.
26. Lemaitre, R. N., T. Tanaka, W. Tang, A. Manichaikul, M. Foy, E. K. Kabagambe, J. A. Nettleton, I. B. King, L. C. Weng, S. Bhattacharya, et al. 2011. Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet. 7: e1002193.
27. Hanada, K. 2003. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim. Biophys. Acta. 1632: 16-30.
28. Hicks, A. A., P. P. Pramstaller, A. Johansson, V. Vitart, I. Rudan, P. Ugocsai, Y. Aulchenko, C. S. Franklin, G. Liebisch, J. Erdmann, et al. 2009. Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet. 5: e1000672.
29. Mullen, T. D., Y. A. Hannun, and L. M. Obeid. 2012. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 441: 789-802.
30. Pewzner-Jung, Y., H. Park, E. L. Laviad, L. C. Silva, S. Lahiri, J. Stiban, R. Erez-Roman, B. Brugger, T. Sachsenheimer, F. Wieland, et al. 2010. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways. J. Biol. Chem. 285: 10902-10910.
31. Quehenberger, O., and E. A. Dennis. 2011. The human plasma lipidome. N. Engl. J. Med. 365: 1812-1823.
32. Dougherty, R. M., C. Galli, A. Ferro-Luzzi, and J. M. Iacono. 1987. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am. J. Clin. Nutr. 45: 443-455.
33. Wu, J. H., R. N. Lemaitre, A. Manichaikul, W. Guan, T. Tanaka, M. Foy, E. K. Kabagambe, L. Djousse, D. Siscovick, A. M. Fretts, et al. 2013. Genome-wide association study identifi es novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Circ. Cardiovasc. Genet. 6: 171-183.
34. Park, T. S., Y. Hu, H. L. Noh, K. Drosatos, K. Okajima, J. Buchanan, J. Tuinei, S. Homma, X. C. Jiang, E. D. Abel, et al. 2008. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J. Lipid Res. 49: 2101-2112.
35. Jiang, X. C., I. J. Goldberg, and T. S. Park. 2011. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. Adv. Exp. Med. Biol. 721: 19-39.
36. Deng, X., X. Yin, R. Allan, D. D. Lu, C. W. Maurer, A. Haimovitz-Friedman, Z. Fuks, S. Shaham, and R. Kolesnick. 2008. Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science. 322: 110-115.
37. Crowder, C. M. 2009. Cell biology. Ceramides-friend or foe in hypoxia? Science. 324: 343-344.
38. Lee, S. Y., J. R. Kim, Y. Hu, R. Khan, S. J. Kim, K. G. Bharadwaj, M. M. Davidson, C. S. Choi, K. O. Shin, Y. M. Lee, et al. 2012. Cardiomyocyte specifi c defi ciency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction. J. Biol. Chem. 287: 18429-18439.
39. Rahmaniyan, M., R. W. Curley, Jr., L. M. Obeid, Y. A. Hannun, and J. M. Kraveka. 2011. Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. J. Biol. Chem. 286: 24754-24764.